Infections caused by non-tuberculous mycobacteria (NTM) are increasing globally and are
notoriously difficult to treat due to intrinsic resistance of these bacteria to many common …

Mycobacteria are a large family of over 100 species, most of which do not cause diseases in
humans. The majority of the mycobacterial species are referred to as nontuberculous …

The incidence of nontuberculous mycobacterial diseases in the United States is rising and
has surpassed that of tuberculosis. Most notable among the nontuberculous mycobacteria is …

Mycobacterium abscessus (M. abscessus) is an opportunistic pathogen usually colonizing
abnormal lung airways and is often seen in patients with cystic fibrosis. Currently, there is no …

Tuberculosis (TB) drug discovery and development has undergone nothing short of a
revolution over the past 20 years. Successful public–private partnerships and sustained …

The Mycobacterium abscessus complex is a group of emerging pathogens that are difficult
to treat. There are no effective drugs for successful M. abscessus pulmonary infection …

Introduction Nontuberculous mycobacterial (NTM) lung disease (LD) is the most common
clinical manifestation of NTM infection and is a growing health concern. Up to 85% of NTM …

Mycobacterium abscessus complex is the most common cause of rapid-grower
nontuberculous mycobacterial pulmonary disease (NTM-PD) and a significant contributor to …

The genus Mycobacterium comprises not only the deadliest of bacterial pathogens,
Mycobacterium tuberculosis, but several other pathogenic species, including M. avium and …

Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary
bypass surgery is high and there is a growing need for a consensus-based expert opinion to …